[Results of a clinical study of an epipodophyllotoxin preparation (VM 26) in children with hemoblastoses].
D002648:Child; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D011034:Podophyllotoxin / Q000031:analogs & derivatives*; D011239:Prednisolone / Q000008:administration & dosage; D013713:Teniposide / Q000008:administration & dosage* / Q000009:adverse effects; D013997:Time Factors
D013713:Teniposide; D011239:Prednisolone; D011034:Podophyllotoxin
Rezul'taty klinicheskogo izucheniia preparata épipodofillotoksina (Vm-26) u deteĭ s gemoblastozami.